A research paper has revealed that children and adolescents who have COVID-19 were at a higher risk of developing major kidney problems post COVID infection, even if they had no prior kidney disease...
This is the first Paxlovid trial out looking at whether Paxlovid would work for Long COVID treatment with the thinking that if the theory of a viral reservoir, or viral persistence is causing the illness then a drug that reduces the virus should help reduce the symptoms. The results of this trial have been talked
Unite to Fight | We envision a world free of Long Covid & ME/CFS stigmatization, where every individual can thrive.
Diagnosing, measuring, and treating Long COVID is complicated, as it can present differently from person to person and persist for months or years